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HeterodimerDNA viruses that induce epithelial lesions in their host. The viral life cycle is
regulated by the family of proteins encoded by the E2 open reading frame. In addition to the full-length E2
protein, the BPV-1 genome encodes two truncated E2 proteins, E2C and E8/E2, which maintain the DNA-
binding-dimerization domains, but lack the activation domain. Heterodimers formed between the full-length
E2 and truncated E2 proteins serve as activators of E2-dependent transcription and papillomavirus DNA
replication. We show that the single activation domain of E2 is sufﬁcient for interaction with viral helicase E1
and for initiation of DNA replication from different papillomavirus origins. Single-chain E2 heterodimer is
able to activate papillomavirus DNA replication in the context of entire BPV genome in the absence of other
E2 proteins. These data suggest that E2 heterodimers with single activation domain are functional in
initiation of papillomavirus replication in vivo.
© 2009 Elsevier Inc. All rights reserved.IntroductionPapillomaviruses are small, double-stranded DNA viruses, which
infect a wide variety of vertebrate species and induce proliferative
epithelial lesions of skin and mucosa in their host. Studies on BPV1
DNA replication have shown the requirement of two virally encoded
proteins, the viral helicase E1 and regulatory protein E2 as well as the
origin region containing E1 and E2 binding sites together with A/T-
rich region for papillomavirus DNA replication (Ustav and Stenlund,
1991; Ustav et al., 1991). The E1 protein binds with low speciﬁcity to
the origin of replication, and speciﬁc and efﬁcient recognition is
achieved by cooperative binding of E1 and E2 to adjacent sites. So, the
E2 protein serves as a loading factor and helps to recruit the viral
helicase E1 to the origin in the initiation of viral DNA replication
within the cells (Sanders and Stenlund, 2001; Sedman and Stenlund,
1995; Sedman et al., 1997).
The E2 open reading frame of BPV1 encodes a family of proteins
which form the central regulatory system of the virus, controlling both
viral gene expression and replication. The E2 protein is a transcription
activator which regulates transcription of viral early promoters
through binding to E2 binding sites (Spalholz et al., 1985). E2
participates in initiation of viral DNA replication by loading viral
helicase E1 onto the origin of DNA replication (Sedman and Stenlund,
1995; Ustav and Stenlund, 1991), and in virus genome episomalll rights reserved.maintenance by tethering viral genomes to mitotic chromosomes
during cell division (Ilves et al., 1999; Lehman and Botchan, 1998). E2
is a modular protein consisting of three different structural as well as
functional domains; the N-terminal transactivation domain (TAD) (aa
1–200), the C-terminal DNA-binding dimerization domain (DBD) (aa
310–410), and ﬂexible unstructured “hinge region”which functions as
a linker between the two functional domains.
In addition to the full-length E2 protein, the BPV-1 genome
encodes two truncated E2 proteins. The full-length E2 is coded by the
entire E2 ORF (bp 2608–3840 of BPV-1 genome); the E2C is translated
from transcript from promoter P3080 with initiator codon correspond-
ing toMet162 in E2; and E8/E2 is translated from alternatively spliced
mRNA-s with splice donor at 1235 and splice acceptor at 3225, thus
fusing 11 aa from E8 ORF to aa 205 of E2 ORF. The two truncated E2
proteins maintain the DNA-binding-dimerization domains of E2, but
lack the activation domain, and therefore act as repressors of E2
dependent transcription. The E2 repressors antagonize the full-length
E2 function by competing for E2 DNA binding sites (Barsoum et al.,
1992; Lambert et al., 1987; Lim et al., 1998). The promoters for full-
length E2 as well as for repressors are themselves controlled by E2
(Baker and Howley, 1987; Li et al., 1989). Despite the E2 repressors
shorter half-life (Hubbert et al., 1988) they predominate in the steady
state (Kurg et al., 2006). However, the ratio of the repressors to
activators changes through the cell cycle (Yang et al., 1991) suggesting
that the balance of different E2 proteins is a key event in the regulation
of virus life cycle. The truncated E2 proteins are able to form
heterodimers with full-length E2 through the common C-terminal
DBD (McBride et al., 1989), and the E2 heterodimers with single
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full-length E2 protein in virus transformed cells (Kurg et al., 2006).
Using the E2 single-chain heterodimer as a model, we have shown
that BPV1 E2 heterodimers can function as activators of transcription
and replication (Kurg et al., 2006).
Most of our knowledge about the role of E2 in papillomavirus DNA
replication is based on studies with the full-length E2 homodimer. In
this study, we have investigated in detail the localization and
replication function of E2 heterodimers with single activation domain.
Our data show that the single activation domain of E2 is sufﬁcient to
localize the E2 protein into cellular chromatin, for interaction with
viral helicase E1 and for initiation of DNA replication from different
papillomavirus origins. E2 heterodimer in the context of entire BPV1
genome is able to initiate the papillomavirus DNA replication, but not
to maintain it for a long time.
Results
Localization of E2 heterodimers is determined by the activation domain
Our previous study has shown that E2 heterodimers with single
activation domain are the preferential form for BPV1 E2 protein in
virus-transformed cells as their amount is four times higher than that
of the full-length E2 homodimer (Kurg et al., 2006). E2 heterodimer
consists of full-length and truncated E2 proteins which cellular
compartmentalization is different: the full-length E2 protein is mostly
associated with cellular chromatin while truncated E2C protein is in
soluble nucleoplasm fraction (Kurg et al., 2005). In order to study the
subnuclear localization of E2 heterodimers with single activation
domain, we have used biochemical fractionation approach as depictedFig. 1. Subnuclear localization of E2 proteins. (A) Schematic representation of E2 proteins use
E2 proteins expressed in BPV1 transformed C127 cells. The UV-treated C127-BPV cells were b
and analyzed by immunoblotting with E2 speciﬁc antibody. Localization of E2 homo- and het
asterisk. Lane 1, 15 ng of bacterially puriﬁed E2 protein. (D) U2OS cells, transfected with 100 n
subjected to biochemical fractionation. Equal volume of each fraction was subjected to SDS-
signal with cellular protein is shown by asterisk.in (Fig. 1B, (Kurg et al., 2005)). First we carried out fractionation of
BPV1-transformed C127 cells, which maintain and replicate the BPV1
genome as an episome and express all three E2 proteins at low,
physiological levels (Hubbert et al., 1988; Kurg et al., 2005). To
examine the localization of E2 dimers in virus transformed cells, the
UV-treated C127-BPV1 cells were biochemically fractionated as
shown in Fig. 1B, and E2 proteins were immunoprecipitated with
E2-speciﬁc 3F12 antibody (Kurg et al., 1999). UV treatment of cells
covalently crosslinks E2 dimers through amino acid Trp360 (Prakash
et al., 1992) allowing us to follow the fractionation proﬁle of E2
hetero- and homodimers in virus transformed cells. The efﬁciency of
UV-treatment is approximately 50% explaining why we can see both,
E2 monomers and E2 heterodimers on the Western blot. As shown on
Fig. 1C, E2 homo- and heterodimers with single activation domain
fractionated similar to the full-length E2 protein: the E2 homodimer
as well as the E2:E2C and E2:E8/E2 heterodimers all fractionated into
0.4 M salt-sensitive chromatin fraction (lanes 4, 5) while E2C
homodimer was found in soluble fraction (lane 2). These data show
that E2 heterodimers composed of full-length E2 protein and E2
repressor localize into the salt-sensitive nuclear chromatin fraction
similar to full-length E2 homodimer.
To determine whether one activation domain is sufﬁcient to
localize the E2 protein into cellular chromatin, we analyzed the
fractionation proﬁle of “single-chain heterodimer” of E2 (scE2)
constructed by fusing the coding region of C-terminal DBD in frame
to the full-length E2 (Fig. 1A). scE2 heterodimer could bind to E2
binding sites similar to the full-length E2 suggesting that this
molecule is structurally and functionally intact and can be used as a
model for E2 heterodimer with single activation domain. Using
“single-chain E2 heterodimer” we have seen only formation ofd in this study. (B) Protocol for biochemical fractionation. (C) Subnuclear localization of
iochemically fractionated, and E2 proteins were immunoprecipitated from all fractions
erodimers is indicated on the right. Non-speciﬁc signal with cellular protein is shown by
g of expression plasmids for E2 or scE2, were fractionated 24 h after electroporation and
PAGE and immunoblotted with HRP-conjugated E2-speciﬁc antibody 5E11. Non-speciﬁc
Fig. 2. Replication function of E2 heterodimer with single activation domain. CHO cells
were transfected with 100 ng of reporter plasmid containing either BPV1 URR region
(A), or E2BS11 or E2BS12 together with E1 binding site (B), 500 ng of expression
plasmid for E1, and 250 ng of expression plasmid for E2 or scE2 and harvested 24, 48
and 72 h after electroporation. Episomal DNA was isolated, digested with DpnI and
linearizing enzyme, and analyzed by Southern blotting using the radiolabeled probe
speciﬁc to the reporter plasmid.
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in several biochemical assays (gel-shift assay, Western blot after UV
crosslinking) used (Kurg et al., 2006). In addition, different biophy-
sical analyses have also conﬁrmed almost identical behavior for E2
DBD homodimer and single-chain species (Dellarole et al., 2007). We
expressed E2 and scE2 in two different cell lines, hamster CHO and
human U2OS cells. As shown on Fig. 1D, lanes 8 and 9, scE2
fractionated similar to wild-type E2 protein into salt-sensitive nuclear
fraction. Similar results were obtained expressing E2 and scE2 in CHO
cells (data not shown). These data suggest once more that one
activation domain is sufﬁcient to localize the E2 protein into cellular
chromatin.Fig. 3. E2:E2C heterodimer activates DNA replication in vivo. (A) CHO cells were transfected
plasmid for E1, and 250 ng of expression plasmid for wild-type E2s or E2mutants, and harves
and linearizing enzyme, and analyzed by Southern blotting using the radiolabeled probe spec
is shown on the left. (B) The average values of the ratio of OriB/OriA signals from two indep
replication of OriB in case of different E2 dimers. Black dots indicate mutation 388/390 in EThe E2 heterodimer with single activation domain activates replication
from different origins
E2 heterodimerwith single activation domain is able to support the
replication of BPV1 origin-containing plasmid pUCAlu (Kurg et al.,
2006). Single-chain E2 heterodimer supports also replication of BPV1
URR-containing plasmid in transient assay, when E1 and E2 expressing
plasmids are transfected into CHO cells together with URR-containing
plasmid (Fig. 2A). The BPV1 minimal origin of replication consists of
two E2-binding sites, E2BS11 and E2BS12, the E1 protein binding site
and the A/T rich region (Ustav et al., 1991). The presence of both E2-
binding sites within the origin is necessary for the full replication
activity in vivo; E2BS11 and E2BS12 play separate but synergistic roles
in the initiation of viral DNA replication that are dependent on their
location within the origin (Gillette and Borowiec, 1998; Sanders and
Stenlund, 2000; Sanders and Stenlund, 2001). In order to test whether
E2 heterodimers function on both, E2BS11 and E2BS12, expression
vectors for E1 and wild-type E2 or scE2 were co-transfected together
with OriA, (containing only E1 distal E2BS11), and OriB (proximal
E2BS12) (Fig. 2B) into CHO cells. As shown on Fig. 2A, scE2
heterodimer is able to support DNA replication of both plasmids
similar to wild-type E2 protein.
To analyze the ability of native E2 heterodimers to support
papillomavirus DNA replication in vivo, we have also used E2 double
mutant 390/388. Alanine substitutions at positions 390/388 severely
reduce the interaction of DBDs of E2 and E1 and disrupt the
interaction between the E2 activation domain and E1 helicase domain,
and therefore are incapable of functioning efﬁciently from the
proximal E2-binding site in OriB. At the same time these mutations
have no effect on replication of OriA containing the distal E2BS11
(Gillitzer et al., 2000) (Fig. 3C). We co-transfected the expression
plasmid for E2 or E2 double mutant 390/388 or E2C or E2C double
mutant 390/388 together with OriA and OriB and with E1 expression
vector into the CHO cells. As expected, both full-length proteins werewith 100 ng of reporter plasmid containing either OriA or OriB, 500 ng of expression
ted 36, 60 and 84 h after electroporation. Episomal DNAwas isolated, digestedwith DpnI
iﬁc to the reporter plasmid. The linearized OriA containing reporter plasmid as a marker
endent experiments. (C) Schematic representation of the ﬁrst steps of the initiation of
2.
Fig. 4. E1 is able to form a complexwith E2 heterodimerwith single activation domain. E2
and HA-tagged E1 proteins were co-expressed in COS-7 cells, and immunoprecipitated
from cell lysates with HA-speciﬁc antibodies. Equal amount of immunoprecipitated
material was subjected to SDS-PAGE and analyzed with HRP-conjugated E2-speciﬁc
antibody 5E11 and HA-speciﬁc antibody 3F12 (Sigma).
Fig. 5. Replication of BPV genome. E2 is expressed as full-length or scE2 within the
context of BPV genome with E2 repressor E2C or both E2C and E8/E2 knockouts. C127
cells transfected with 3 μg of respective BPV genome and harvested 3, 6, 8 or 11 days
after electroporation. Episomal DNA was isolated, digested with DpnI and linearizing
enzyme, and analyzed by Southern blotting using the radio-labeled probe speciﬁc to the
reporter plasmid.
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while only the wild-type E2, but not E2 mutant 390/388, was able to
support efﬁciently the replication of OriB (lower band). E2C and E2C
mutant 390/388 were inactive in supporting replication of both Oris
(lanes 4, 5). Next, co-transfection of the expression plasmids for E2
mutant 390/388 and E2C together with OriA and OriB was carried out.
Co-expression of E2 mutant 390/388 and E2C results in the formation
of E2(390/388) homodimers, E2(390/388):E2C heterodimers and
E2C homodimers from which the latter is not able to support
papillomavirus DNA replication, and E2(390/388) homodimer is
able to support replication of OriA only (Fig. 3A; lane 3, upper band).
Thus, efﬁcient replication of OriB can be achieved only by E2(390/
388):E2C heterodimers. Indeed, as shown on Fig. 3A, the heterodimer
consisting of E2 mutant 390/388 and E2C was able to support
replication of both, OriA and OriB (lane 7) suggesting that E2
heterodimer containingone activation domain and only one functional
DBD is active for replication of OriB. When both proteins, E2 and E2C,
carried mutation, the replication was initiated much more efﬁciently
from OriA compared to OriB (Fig 3A, lane 8), like in case of E2(390/
388) alone (lane 3). The replication signals were quantiﬁed using
PhosphoImager SI (Molecular Dynamics) and the ratio of signals of
OriB andOriA is shown graphically in the diagram in Fig. 3B. These data
show that the native E2 heterodimers are able to support DNA
replication of papillomavirus origin within the cells.
The E2 protein with single activation domain interacts with E1
The role of E2 in DNA replication is to target viral helicase E1 to its
cognate binding site by cooperative binding with E1. The cooperative
binding is mediated by an interaction between the activation domain
of E2 and E1. To determine whether E1 is able to form a complex with
E2 heterodimers with single activation domain, we co-transfected the
COS-7 cells with expression plasmids for E1 and E2 proteins, and
immunoprecipitated E1:E2 complex with anti-E1 antibodies. The E1
protein used in this study contains N-terminally fused HA epitope tag
and we have used anti-HA antibodies in this assay. As shown in Fig. 4,scE2 heterodimer was able to co-immunoprecipitate with E1 with the
same efﬁciency as the full-length E2 protein (lanes 3 and 4). However,
under competitive conditions, when both, E2 and scE2 heterodimers,
were expressed together with the E1 protein, E1 interacted better
with scE2 heterodimer (lane 5). The E2 and E1 proteins were
expressed at comparable levels (Fig. 4, lower panel) and E2 proteins
were not precipitated from the cell lysate when E1 was not present
(lane 2). The antibody was captured from all preparations equally well
as tested in Western blot against mouse IgG (data not shown). These
data suggest that E1 is able to form a complex with E2 heterodimer
similar to full-length E2 homodimer, and furthermore, interacts with
monomeric E2 activation domain better than with dimeric E2.
E2 heterodimer with single activation domain initiates BPV1 genome
replication
In order to follow the ability of scE2 heterodimer to support
papillomavirus DNA replication in the context of the whole BPV
genome, we have replaced the open reading frame of E2 with scE2
sequence in the context of the entire BPV1 genome using BPV mutant
genomes E2C− and, double mutant E2C−E8/E2− where initial ATG
codons of E2C or E2C and E8/E2 have been mutated, respectively. The
mutated BPV1scE2 genomes encode only E2 proteins with two DBDs,
and presumably only intramolecular dimers are formed. For instance,
BPVscE2_E2C− genome encodes scE2 heterodimer, and pre-formed
E8/E2 homodimer, while BPVscE2_E2C−E8/E2− encodes only scE2
protein because E2C and E8/E2 open reading frames are mutated. E2C
is the major E2 repressor protein and disruption of this gene alters
the relative abundance of E2 transactivator to E2 repressor resulting
in ten fold increase in E2 transcriptional activity and ten to twenty
fold increase in viral copy number (Lambert et al., 1990). In our
experiment, we have used BPV E2C− genome because the replication
signal of wild-type BPV genome in C127 cells was very low and
remained sometimes under detection level. The mutated BPV
genomes were transfected into C127 cells and low molecular weight
DNA was isolated at days 3, 6, 8 and 11 after electroporation. As
shown on Fig. 5, transient replication signals were detected in all
cases up to 8 days after transfection using either wild-type or
mutated BPV genomes. But on day eleven, transient replication
signals of BPV_E2C−E8E2− genome and both BPVscE2 genomes
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increased (Fig. 5, compare lanes 8, 12, 16 and 4). As shown by
Lambert et al., the disruption of both E2 repressor proteins, E2C and
E8/E2 severely reduces the copy number of BPV genomes after
several passages of transformed cells (Lambert et al., 1990). We
observed the same phenomena with BPV_E2C−E8E2− genome
11 days after transfection of cells (Fig. 5). The replication signals of
both BPVscE2 genomes also decreased in course of time and were
undetectable in day eleven after transfection. Our earlier studies have
shown that scE2 heterodimer does not support the partitioning of
viral genomes in dividing cells (Kurg et al., 2006) and this may be the
explanation for reduced replication signals of BPVscE2 genomes after
several cell divisions. However, these data suggest that E2 hetero-
dimer with single activation domain alone is able to initiate
papillomavirus DNA replication in the context of entire viral genome.
Discussion
The E2 ORF encodes a family of proteins which form the central
regulatory system of the virus. The full-length E2 protein acts as
positive regulator of replication while shorter forms of E2, lacking the
activation domain, serve as repressors of replication and transcription.
It has been thought for years that heterodimers of full-length and
repressor forms are unstable and act as negative regulators. In our
previous study (Kurg et al., 2006), we showed that in virally infected
cells, the full-length E2 protein forms heterodimers with repressor
forms of E2 and these heterodimers are the preferential form for full-
length E2 protein in virus transformed cells. In addition, the forced
heterodimers of full-length E2 with repressor form could mediate
transactivation and replication of papillomavirus DNA (Kurg et al.,
2006). In the present study, we go further and provide evidence that
E2 heterodimers with single activation domain are able to initiate BPV
replication in the context of papillomavirus genome in the absence of
other E2 proteins.
In the present study, we show that E2 heterodimer consisting of the
full-length and truncated E2 protein associateswith cellular chromatin
similar to the full-length E2 suggesting that this localization is
determined by the single activation domain. This result was not
surprising as E2 heterodimer is able to support papillomavirus DNA
replication and transcription, and for these activities E2 requires
several different cellular interaction partners. However, E2 homo- and
heterodimer interact differently with some proteins. E2 requires only
one activation domain for complex formation with viral helicase E1
and two domains for interactionwith cellular Brd4 protein (Kurg et al.,
2006). It has been previously reported that E2 binds to Brd4 most
efﬁciently as a dimer (Cardenas-Mora et al., 2008) and this interaction
is important for E2-mediated transcriptional regulation (Ilves et al.,
2006). E2 point-mutation R37A disrupting the N-terminal dimeriza-
tion surface (Hernandez-Ramon et al., 2008) had a major effect on
transactivation and did not affect replication (Abroi et al., 1996). These
results are consistent with our previous study showing that E2
heterodimerswith single activationdomain areweaker transactivators
than E2 dimer with two activation domains (Kurg et al., 2006).
Our data show that E2 heterodimers form a complex with E1 and
are able to load the viral helicase E1 to the origin of replication. The
scE2 heterodimer forms complex with E1 in solution as efﬁciently as
with full-length E2 protein or even better, and is a preferred partner
for E1 at competitive conditions. These data are supported by earlier
studies. First, Lim et al. showed that pre-formed E2:E2C heterodimers
enhance the binding of E1 to the origin of replication in vitro as
efﬁciently as E2 homodimer and can activate DNA replication in a cell-
free system (Lim et al., 1998). Second, two recent works have shown
that disruption of N-terminal dimerization of BPV1 and HPV16 E2
proteins does not affect replication suggesting that monomeric
transactivation domain is functional in replication (Hernandez-
Ramon et al., 2008; Sanders et al., 2007). The use of monomericactivation domain together with dimeric activation domain in loading
E1 molecules may be important for introduction of conformational
heterogeneity in loaded E1 molecules which in turn is required for
sequential ATP hydrolysis by double hexameric E1 (Enemark and
Joshua-Tor, 2006). We suggest that E2 homo- and heterodimers work
in concert in viral DNA replication. Efﬁcient formation of E1:E2
complex is only one step in initiation of papillomavirus DNA
replication, E2 has additional activities in papillomavirus DNA
replication within the cells. E2 is able to alter chromatin structure
within the origin and through this facilitate the initiation of DNA
replication (Li and Botchan, 1994). For this activity virus needs
probably full-length E2 homodimers as at least two E2 binding sites
are required for its chromatin remodeling activity in yeast model
(Lefebvre et al., 1997). The full-length E2 homodimer is also required
for long-term persistence of viral genomes as the E2 heterodimers
with single activation domain are crippled in the segregation of viral
genomes (Kurg et al., 2006).
Genetic studies showing that at least one of two E2 repressors of
BPV1 is required for the long-term maintenance of viral genomes and
for the virus transforming activity (Lambert et al., 1990; Lehman et al.,
1997) demonstrate the important role of truncated E2 proteins in the
viral life cycle. Disruption of E2C results in ten fold increase in E2
transcriptional activity and ten to twenty fold increase in viral copy
number. However, disruption of both E2 repressor proteins, E2C and
E8/E2, reduces severely the copy number of BPV genomes (Lambert
et al., 1990). Our results presented in this study are consistent with
theseworks and support the concept that truncated forms of E2 have a
critical regulatory role on E2 function, and suggest that a very well
orchestrated control of papillomavirus maintenance and copy number
is achieved by the balance of different E2 proteins.
The intriguing question is what is the possible role for E2
heterodimers in virus life cycle and is it essential? Our recent works
have shown that E2 heterodimers are able to initiate virus DNA
replication, but not to segregate and maintain the virus genome (Kurg
et al., 2006). This is supported by the work of Yang et al. where the
dynamic change in the balance of E2 repressors to activators within
the cell cycle was measured. In asynchronous and G1 cells, the E2
repressors dominate, but in late S phase and G2/M, the activator is
present in about equal levels to that of the repressors (Yang et al.,
1991). We also show that the E2 protein can be replaced with scE2
heterodimer in the context of BPV genome and these scE2 genomes
replicate in transient assays in the absence of other E2 proteins. One
possibility is that E2 heterodimers are essential for quick ampliﬁcation
of virus genomes taking place within limited number of cell cycles,
and full-length E2 homodimer for maintenance of viral genomes in
dividing cells. This hypothesis is supported by the work of Szymanski
and Stenlund (1991) who have analyzed the transcriptional activity of
BPV promoters in their natural genomic context. In the absence of E2,
the level of P3080-speciﬁc messages was more than 10-fold greater
than the level of any other promoter suggesting that BPV early
promoter P3080 expressing E2C repressor protein is the most
productive promoter upon initial viral infection while P89 and P2443
expressing full-length E2 have low basal activity. In addition, BPV early
promoters display differential sensitivities to the E2 protein, and the
P3080 was the least responsive to E2 (Szymanski and Stenlund, 1991)
suggesting that synthesis of E2 and E2C are differently regulated by
E2. So, the level of E2C is high and full-length E2 is low upon initial
viral infection, but after some time the level of full-length E2 is
increasing due to positive autoregulation of E2 expression. The
abundance of E2 and E2C mRNAs is quantitatively different between
the transiently transfected and stably transformed cells (Szymanski
and Stenlund, 1991). Presumably the level of E2 heterodimer with
single activation domain is also initially high, and the ratio of E2
homo- and heterodimers is changing during the course of the viral
infection. These ﬁndings, together with our results that E2 hetero-
dimers with single activation domain are able to initiate BPV
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between these two forms of E2, are important for regulation of virus
replication and stable plasmid copy number in papillomavirus-
transformed cells.
Materials and methods
Cell culture and plasmids
Chinese hamster ovary (CHO) cells were propagated in Ham's F12
medium, C127-BPV1, U2OS and Cos7 cells in Iscove's modiﬁed
Dulbecco's medium, both supplemented with 10% fetal calf serum.
The transfections were carried out by electroporation as described in
Ustav et al. (1991), applying 230 V in case of CHO cells and 180 V in
case of Cos7 and U2OS cells. All the expression vectors used in this
study have been described previously — BPV1 E2 expression vectors
pCGE2, pCGE2C, pCGE8/E2 in Ustav and Stenlund (1991), expression
vector for single-chain heterodimer pCGE2∼DBD(310) in Kurg et al.
(2006), pCGEpiEag in Ustav and Stenlund (1991). The protein
expressed by vector pCGE2∼DBD(310) is called scE2 here, and
contains full-length E2 ORF together with extra copy of DBD of E2
starting from amino acids 310. The E2 mutant 388/390 was made
from pCGE2 by changing the codons corresponding to aa 388 and 390
to Ala codons GCT and GCG, respectively. The pCGE2 and pCGE2_388/
390 have both the Ile at position 162 instead of Met, so no E2C is
produced. To disrupt the E2C and E8 genes in the context of BPV
genome, missense mutations were generated by altering G to C at nt
3093 and T to C at nt 1205, respectively. Restriction enzyme PﬂMI site
was used to clone the additional DBD fragment from pCGE2∼Gly14-
DBD(310) (Kurg et al., 2006) into pML-BPV plasmid and its derivatives
(Lusky and Botchan, 1984).
Biochemical fractionation and immunoblotting
Biochemical fractionation of the transfected CHO and U2OS cells
(1–2×106) was performed as described previously (Kurg et al., 2005).
Shortly, the cytosol and nucleosol were extracted with CSK buffer
(10 mM PIPES pH 6.8, 300 mM sucrose, 100 mM NaCl, 3 mM MgCl2,
1mMEGTA,1mMDTT,1mMPMSF, protease inhibitors) supplemented
with 0.5% (vol/vol) Triton X-100, cell lysateswere centrifuged, and the
pellets were resuspended in CSK buffer containing either 0.1 or 0.4 M
NaCl. After 10 min of incubation, the soluble and insoluble fractions
were separated by centrifugation. Proteins from each fraction were
separated by SDS-PAGE and transferred to PVDF membrane. Material
from equal number of cells was loaded on each lane. Membrane was
incubated with HRP-conjugated 5E11 antibody (1 μg/ml) (Kurg et al.,
1999). Chemoluminescent signal was detected using ECL kit from
Amersham Biosciences.
Biochemical fractionation of UV treated C127-BPV1 (1,5–2×107)
cells was done as noted above and E2 proteins from all fractions were
immunoprecipitated with immobilized 3F12 antibodies and subjected
to subsequent immunoblotting with HRP conjugated 5E11 antibody
(Quattromed AS, Tartu, Estonia) as described in Kurg et al. (2005).
Mab 3F12 recognizes aa 199–206 of full-length E2; this epitope is
present in E2 repressor E2C, but is missing in E8/E2 (Kurg et al., 1999).
Coimmunoprecipitation
To determine the E1:E2 complexes, COS-7 cells (∼2×106) were
transfected with 1000 ng of pCGEpiEag plasmid expressing HA-tagged
E1 protein and with 500 ng of pCGE2 or pCGE2-DBD(310) to express
E2 or scE2. The cells were collected 40 h post transfection, washed
with PBS and lysed on ice for 20 min in 100 μl of lysis buffer (LB)
(50 mM Tris–HCl; pH 7.5; 5 mM EDTA; 1% IGEPAL; 10 mM DTT;
0.5 mM PMSF; 10% glycerol, protease inhibitor coctail (Roche)) with
0.15 M NaCl. The unsoluble fraction was pelleted by centrifugation for5 min at 13,000 g at 4 °C. Then 30 μl of soluble fraction was incubated
at RT for 45 min to allow the formation of E1:E2 complex which has
been shown to be cold sensitive (Benson and Howley, 1995), and
300 μl of LB with 0.4 M NaCl was added together with 2 μg of HA7
antibody (Sigma H9658). After incubation at 4 °C for 90 min with
agitation, 1.5 μl of ProteinG-Sepharose (Amersham) beads were added
to each tube and incubated for 2 h at 4 °C with agitation. Then beads
were washed 2×10 min with 250 μl of LB supplemented with 0.4 M
NaCl at 4 °C and once with the same volume of LB together with 0.5 M
NaCl at RT and once with 200 μl LB (without salt) for 5 min. The beads
were resuspended in SDS loading buffer and heated for 5 min at 95 °C.
Immunoprecipitated proteins were separated by SDS-polyacrylamide
gel electrophoresis and transferred by semidry-blotting method to a
polyvinylidine diﬂoride (PVDF) membrane (Millipore Corp). The E2
proteins were detected with 5E11-HRP conjugate (Quattromed AS,
Tartu, Estonia) and E1was detectedwith 3F10-HRP conjugate (Sigma)
using ECL detection kit (Amersham Pharmacia Biotech) following
manufacturer instructions.
Replication assay
The OriA and OriBwere created into the backbone of NdeI− version
of pUCAlu (Ustav et al., 1993) (pUCAlu plasmid was linearized with
NdeI, ﬁlled in and religated to destroy potential E2 BS in vector
backbone). In case of OriA, E2 BS12 was deleted and the plasmid
contains BPV1 nucleotides 7893–15. In case of OriB, the E2 BS11 was
deleted and the plasmid contains BPV1 nucleotides 7908–52. The
respective sequences were veriﬁed by sequencing. For replication
assay, CHO cells were electroporated with 100 ng of pUCAlu DNA or
100 ng of OriA and OriB DNA, 500 ng of pCGEag and 250 ng of pCGE2
or its derivatives. Low molecular weight DNA was isolated, cut with
DpnI and CaiI and analyzed by Southern blot analysis as described in
Ustav and Stenlund (1991). The CaiI restriction endonuclease
discriminates OriA and OriB resulting of fragments of 2742 bp, and
1988+788 bp, respectively.
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